Patent ID: 8586594
Filing Date: 2013-11-19
Classification: A61P,C07C,C07D

Abstract:
1. A method for treating a disorder selected from the group consisting of type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, and non-alcoholic fatty liver disease, said method comprising the step of administering to a subject in need thereof a compound of formula (I), wherein Q is phenyl or a monocyclic heteroaryl optionally substituted with 1, 2 or 3 substituents as represented by T, wherein each T is independently alkyl, alkenyl, alkynyl, halogen, —CN, —NO A is formula (a) wherein V R R R r and s are independently 1 or 2; X is X X X R R wherein the cycloalkenyl, cycloalkyl, heterocycle, heteroaryl, aryl, the aryl moiety of the arylalkyl, and the heteroaryl moiety of the heteroarylalkyl as represented by X t, u, v and w, at each occurrence, are each independently 1, 2, 3, 4, 5, or 6; R R R or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.